Total synthesis of novel antibiotics pyloricidin A, B and C and their application in the study of pyloricidin derivatives

被引:10
作者
Hasuoka, A
Nishikimi, Y
Nakayama, Y
Kamiyama, K
Nakao, M
Miyagawa, K
Nishimura, O
Fujino, M
机构
[1] Takeda Chem Ind Ltd, Div Pharmaceut Res, Med Chem Res Labs 1, Yodogawa Ku, Osaka 5328686, Japan
[2] Takeda Chem Ind Ltd, Mkt Div, Vaccine Grp, Chuo Ku, Osaka 5408645, Japan
[3] Takeda Chem Ind Ltd, Div Pharmaceut Res, Pharmaceut Discovery Ctr, Yodogawa Ku, Osaka 5328686, Japan
[4] Takeda Chem Ind Ltd, Div Pharmaceut Res, Tsukuba, Ibaraki 3004293, Japan
[5] Takeda Chem Ind Ltd, Chuo Ku, Osaka 5328645, Japan
关键词
D O I
10.7164/antibiotics.55.191
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The novel natural antibiotics pyloricidin A, B and C, which possess potent and highly selective anti-Helicobacter pylori activity, were synthesized from D-galactosamine as a chiral template for the common (2S,3R,4R,5S)-5-amino-2,3,4,6-tetrahydroxyhexanoic acid moiety. The synthetic strategy, using 2-amino-2-deoxyuronic acid derivatives as key intermediates, was also useful to prepare a series of derivatives modified at the beta-D-phenylalanine and with altered stereochemistry on the 5-amino-2,3,4,6-tetrahydroxyhexanoic acid moiety. From the drastic decrease of their anti-H. pylori activity, it was clear that the beta-D-phenylalanine part and the stereochemistry of the 5-amino-2,3,4,6-tetrahydroxyhexanoic acid moiety were significant for the activity.
引用
收藏
页码:191 / 203
页数:13
相关论文
共 20 条
  • [11] MANNES GA, 1993, EUR J GASTROEN HEPAT, V5, P145
  • [12] Pyloricidins, novel anti-Helicobacter pylori antibiotics produced by Bacillus sp.: II.: Isolation and structure elucidation
    Nagano, Y
    Ikedo, K
    Fujishima, A
    Izawa, M
    Tsubotani, S
    Nishimura, O
    Fujino, M
    [J]. JOURNAL OF ANTIBIOTICS, 2001, 54 (11) : 934 - 947
  • [13] Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori
    Nakao, M
    Malfertheiner, P
    [J]. HELICOBACTER, 1998, 3 (01) : 21 - 27
  • [14] Pyloricidins, novel anti-Helicobacter pylori antibiotics produced by Bacillus sp.: I.: Taxonomy, fermentation and biological activity
    Nakao, M
    Miyagawa, K
    Nakano, Y
    Sakane, T
    Tada, M
    Nishimura, O
    Fujino, M
    [J]. JOURNAL OF ANTIBIOTICS, 2001, 54 (11) : 926 - 933
  • [15] HIGH-FIELD FT NMR APPLICATION OF MOSHER METHOD - THE ABSOLUTE-CONFIGURATIONS OF MARINE TERPENOIDS
    OHTANI, I
    KUSUMI, T
    KASHMAN, Y
    KAKISAWA, H
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (11) : 4092 - 4096
  • [16] GASTRIC ADENOCARCINOMA AND HELICOBACTER-PYLORI INFECTION
    TALLEY, NJ
    ZINSMEISTER, AR
    WEAVER, A
    DIMAGNO, EP
    CARPENTER, HA
    PEREZPEREZ, GI
    BLASER, MJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (23) : 1734 - 1739
  • [17] WARREN JR, 1983, LANCET, V1, P1273
  • [18] Helicobacter pylori infection induces gastric cancer in Mongolian gerbils
    Watanabe, T
    Tada, M
    Nagai, H
    Sasaki, S
    Nakao, M
    [J]. GASTROENTEROLOGY, 1998, 115 (03) : 642 - 648
  • [19] INVITRO SUSCEPTIBILITY OF HELICOBACTER-PYLORI TO THE NEW ORAL CEPHALOSPORINS CEFPODOXIME, CEFTIBUTEN AND CEFIXIME
    WESTBLOM, TU
    GUDIPATI, S
    MIDKIFF, BR
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (09) : 691 - 693
  • [20] YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65